An open-label trial of JAK 1/2 blockade in progressive IFIH1-associated neuroinflammation

Kothur, K; Bandodkar, S; Chu, S; Wienholt, L; Johnson, A; Barclay, P; Brogan, PA; Rice, GI; Crow, YJ; Dale, RC

Dale, RC (reprint author), Univ Sydney, Childrens Hosp Westmead, Sydney, NSW, Australia.

NEUROLOGY, 2018; 90 (6): 289

Abstract

IFIH1 gain-of-function causes a spectrum of neuroinflammatory phenotypes associated with enhanced type I interferon production and Janus kinase (JAK)/......

Full Text Link